Page 5,430«..1020..5,4295,4305,4315,432..5,4405,450..»

What Drugs Are They On – Video

Posted: Published on April 17th, 2013

What Drugs Are They On By: FunZoneization … Continue reading

Posted in Drugs | Comments Off on What Drugs Are They On – Video

Amanda Bynes 2013 Doing Drugs (VIDEO) – Video

Posted: Published on April 17th, 2013

Amanda Bynes 2013 Doing Drugs (VIDEO) AMANDA PLEASE get some help, whilst this breakdown is entertaining it's sad seeing one of my childhood idols end up like this! By: Sally Murs … Continue reading

Posted in Drugs | Comments Off on Amanda Bynes 2013 Doing Drugs (VIDEO) – Video

Breast cancer drugs may help high-risk, healthy women

Posted: Published on April 17th, 2013

Doctors should talk about breast cancer-reducing drugs with women and offer tamoxifen or raloxifene to those that have a high risk of cancer and aren't likely to suffer side effects, a government-backed panel said on Monday. The drugs work by blocking the effects of estrogen in breast tissue, lowering the chance of hormone-related cancers. But they also increase the risk of blood clots and hot flashes, among other side effects - so they shouldn't be handed out to everyone, the U.S. Preventive Services Task Force (USPSTF) said in its new draft guidelines. "Currently only a minority of women for whom the medication might be indicated are actually taking it," said Dr. Mark Ebell, a member of the Task Force from the University of Georgia College of Public Health in Athens. "I don't think there's a right or wrong answer for women," he told Reuters Health. "The main thing is just for women to be aware of this as an option and to talk to their doctor if they think they might be at increased risk." Women are considered at high risk if they have a five-year chance of developing breast cancer of at least one in 60. Tools such as … Continue reading

Posted in Drugs | Comments Off on Breast cancer drugs may help high-risk, healthy women

Frost & Sullivan: New Drug Candidates Hold Tremendous Promise for European HIV Drugs Market

Posted: Published on April 17th, 2013

LONDON, April 17,2013 /PRNewswire/ -- The anticipated launch of drugs currently in the pipeline, together with the introduction of oral combination pills, are set to have a profound impact on the European HIV drugs market. New analysis from Frost & Sullivan (http://www.lifesciences.frost.com), Analysis of the European HIV Drugs Market, finds that the market earned $5.58 billion in 2012 and estimates this to reach $9.24 billion in 2019. The research covers the most actively used antiretroviral (ARV) therapies: nucleoside reverse transcriptase inhibitor (NRTI), protease inhibitor (PI), non-nucleoside reverse transcriptase inhibitor (NNRTI), integrase inhibitors, and other therapeutics (ARV compounds like CCR5 receptor antagonists, fusion inhibitors, maturation inhibitors, attachment inhibitors and PK boosters). "In addition to popularly existing therapies like NRTI, NNRTI, PI and integrase inhibitors, new drug candidates over the last decade have spurred the HIV drugs market," notes Frost & Sullivan Healthcare Research Analyst Deepika Pramod Chopda. "The development of new candidates, derived from the less commonly used types of ARV therapies like PK boosters, maturation inhibitors, and attachment inhibitors, is driving the overall market." With technically advanced features like easy consumption and higher adherence to combination therapy, these candidates assist highly active antiretroviral therapies (HAART), which are a combination of … Continue reading

Posted in Drugs | Comments Off on Frost & Sullivan: New Drug Candidates Hold Tremendous Promise for European HIV Drugs Market

Drugs Can Cut Breast Cancer Risk for Some, Task Force Finds

Posted: Published on April 17th, 2013

By Carina Storrs HealthDay Reporter MONDAY, April 15 (HealthDay News) -- The drugs tamoxifen and raloxifene (Evista) could reduce the risk of breast cancer among women who are at high risk of developing the disease, a new report confirms. Along with the report, the U.S. Preventive Services Task Force also issued draft recommendations that reflect those findings, which will be published in the April 16 issue of the Annals of Internal Medicine. The task force recommendations state that doctors should talk about the potential benefits and harms of taking drugs to prevent breast cancer, a strategy known as chemoprevention, with patients who are at high risk of developing breast cancer. That guideline is consistent with that of the American College of Obstetricians and Gynecologists and the American Cancer Society, and reflects current clinical practice, the task force said. "We had a nice set of well-done, large [studies], so we have a lot of confidence in the results to really inform the recommendations," said report author Dr. Heidi Nelson, a research professor of medical informatics and clinical epidemiology at the Oregon Health and Science University in Portland. Nelson and the other report authors are not task force members and were contracted … Continue reading

Posted in Drugs | Comments Off on Drugs Can Cut Breast Cancer Risk for Some, Task Force Finds

Research and Markets: Distribution on the Pharmaceutical Market in Poland 2013

Posted: Published on April 17th, 2013

DUBLIN--(BUSINESS WIRE)-- Research and Markets has announced the addition of the "Distribution on the Pharmaceutical Market in Poland 2013" report to their offering. The distribution network for pharmaceutical products in Poland is made up of several main channels, including wholesale, pharmacy, non-pharmacy and direct and online sales. Pharmacy memberships in larger chains have been on the rise and are expected to continue to expand in the coming years. Find out which specific market developments and trends are causing this shift, and resulting in other changes to the volume and value of the major distribution channels that bring pharmaceuticals into the hands of Polish consumers by reading Distribution on the pharmaceutical market in Poland 201. Impact of the Reimbursement Act and development forecasts for 2013-2015, the PMR publication created with the needs of pharmaceutical industry professionals in mind. This innovative report compiles all relevant data, analysis and forecasts for each market segment into one convenient and easy to use document. The publication examines the companies setting the pace in Poland's pharmaceutical distribution sector through detailed profiles that include financial data, strategic updates, market shares and planned activities. It explores the entire wholesale distribution segment, including non-pharmacy and hospital sales. It describes … Continue reading

Posted in Online Pharmacy | Comments Off on Research and Markets: Distribution on the Pharmaceutical Market in Poland 2013

Pharmacy students lobby lawmakers for building funds

Posted: Published on April 17th, 2013

Student pharmacists from The Daniel K. Inouye College of Pharmacy at the University of Hawai'i at Hilo visited the State Capitol on Tuesday to deliver informational packets to legislators. Lawmakers are deliberating the fate of funding a permanent building for the college. UH says the accreditation of the college is at risk, which is being evaluated by committee members from the Accreditation Council for Pharmacy Education. The conference committee is the final hurdle for legislation before heading to state House and Senate floor votes in early May. The state Senate has included the $38 million needed for the building in its budget, but the House has not. The informational packets, including a CD with 1,000 letters of community support and petitions with 1,243 signatures, are a product of a group of community members called the Friends of The Daniel K. Inouye College of Pharmacy Steering Committee, headed by Kelvin Sewake, a Hilo resident. "The community has really come out in full support of the College, and for that we are truly grateful," said Sewake, who also is the father of a student pharmacist. "The letters and petitions represent the hopes and dreams of the current pharmacy students as well as … Continue reading

Posted in Pharmacy | Comments Off on Pharmacy students lobby lawmakers for building funds

NuVision Pharmacy Announces Voluntary Nationwide Recall Of All Lots Of All Lyophilized Products Compounded by NuVision …

Posted: Published on April 17th, 2013

NuVision Pharmacy is voluntarily recalling all unexpired lots of lyophilized compounds HcG 5000IU-5ml and Sermorelin/GHRH6-5ml to the user level. The recall is being initiated due to a lack of sterility assurance and concerns associated with the quality control processes identified during the FDA inspection. In the event a sterile product is compromised patients are at risk for serious and possible life threatening infections. To date, NuVision Pharmacy has received no reports of injury or illness associated with the use of our sterile products. However, out of abundance of caution and in the interest of our patients, NuVision Pharmacy has decided to voluntarily proceed with this recall process. These products were supplied to the offices of licensed medical professionals. NuVision Pharmacys sterile products covered under this recall were distributed nationwide. NuVision Pharmacy is notifying its customers by fax or email to return the products to the pharmacy. Consumers or Health Care providers with questions regarding this recall may contact NuVision Pharmacy by phone at 800-914-7435 on Monday through Friday from the hours of 10 am to 6 pm CST, or by e-mail at pharmacist@nuvisionpharmacy.com. Patients who have received any product distributed by NuVision Pharmacy and have concerns should contact their healthcare … Continue reading

Posted in Pharmacy | Comments Off on NuVision Pharmacy Announces Voluntary Nationwide Recall Of All Lots Of All Lyophilized Products Compounded by NuVision …

Report: FDA had many complaints on Mass pharmacy

Posted: Published on April 17th, 2013

WASHINGTON (AP) -- House Republicans said Tuesday that the Food and Drug Administration should have acted years earlier to close the Massachusetts pharmacy responsible for a deadly meningitis outbreak tied to contaminated medications. A report issued by Republicans blasts the FDA for failing to act on years of complaints about problematic drugs and practices at the New England Compounding Center. The compounding pharmacy produced tainted pain injections that have sickened more than 700 Americans and killed 53 others. The wave of infections was first identified in September and grew into one of the deadliest medication-related outbreaks in U.S. history. The NECC halted operations in October and faces over 100 lawsuits in federal court. But more than half-year later, lawmakers in Washington continue to debate whether the public health crisis could have been prevented. Republicans on the House subcommittee investigating the outbreak said that the FDA should have closed the NECC based on complaints from doctors, patients, hospitals and drug distributors. The FDA first inspected the pharmacy in 2002 and issued a warning letter in 2006 for mass-producing copies of manufactured drugs. Beginning in 2007 and continuing through 2012 the FDA continued to receive complaints about the company from anonymous informants … Continue reading

Posted in Pharmacy | Comments Off on Report: FDA had many complaints on Mass pharmacy

Attorney Derek Merman Represents Compounding Pharmacy Recall Victims Nationwide

Posted: Published on April 17th, 2013

HOUSTON, April 17, 2013 /PRNewswire/ -- Attorney Derek Merman from The Merman Law Firm,located in Houston, Texas is accepting additional clients who are victims of compounding pharmacy recalls -- recalls which seem to be announced on an increasingly routine basis. For example, in 2011, 2012, and most recently in 2013, compounding pharmacies have been responsible for contaminated drugs that have caused serious infections, vision loss, and an alarming outbreak of fungal meningitis, which resulted in serious illnesses and deaths. For good reason, these pharmacies' practices are drawing scrutiny from the Food and Drug Administration. (Photo: http://photos.prnewswire.com/prnh/20130417/PH95165-a) (Photo: http://photos.prnewswire.com/prnh/20130417/PH95165-b) A compounding pharmacy is a practice in which a licensed pharmacist combines, mixes, or alters ingredients in response to a prescription to create a medication tailored to the medical needs of an individual patient. The FDA recognizes that pharmacy compounding, performed as it was originally intended, provides an important service if a patient cannot be treated with an FDA-approved medication. For example, a compounding pharmacy may alter an FDA-approved drug to ensure that an ingredient the patient is allergic to is eliminated, or to change the medication's form from a pill to a liquid. The compounding pharmacy industry is growing, and in … Continue reading

Posted in Pharmacy | Comments Off on Attorney Derek Merman Represents Compounding Pharmacy Recall Victims Nationwide

Page 5,430«..1020..5,4295,4305,4315,432..5,4405,450..»